The Department of Defense’s Neurofibromatosis Clinical Trial Award supports research aiming to impact NF treatment. It funds clinical trials testing new products, drugs, devices, or technologies, from pilot trials to large-scale efficacy studies. This grant focuses on human subject interventions for outcomes like safety and effectiveness, excluding preclinical research. PIs should provide scientific rationale and data, varying by trial phase. Applicants should seek alternative funding for preclinical studies. The award targets researchers conducting human-focused trials to advance NF management. Application deadline is Jul 27, 2015.
Opportunity ID: 276380
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-15-NFRP-CTA |
| Funding Opportunity Title: | DoD Neurofibromatosis Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 06, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 27, 2015 |
| Current Closing Date for Applications: | Jul 27, 2015 |
| Archive Date: | Aug 26, 2015 |
| Estimated Total Program Funding: | $2,880,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept (i.e., pilot, first in human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered by FY15 NFRP. The term “human subjects” is used in this Program Announcement/Funding Opportunity to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm. For Pilot trials, inclusion of scientific rationale and/or preliminary data relevant to the proposed pilot clinical trial is required. For Phase I or II trials, both scientific rationale and preliminary data relevant to the proposed clinical trial are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 276380 Full Announcement-1 -> nfrp_fy15_cta_pa_gg.pdf
Folder 276380 Full Announcement-1 -> nfrp_fy15_cta ind documenation form_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00216685 | May 06, 2015 | Jul 27, 2015 | View |
Package 1
Mandatory forms
276380 RR_SF424_2_0-2.0.pdf
276380 RR_Budget_1_3-1.3.pdf
276380 RR_KeyPersonExpanded_2_0-2.0.pdf
276380 PerformanceSite_2_0-2.0.pdf
Optional forms
276380 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
